| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ABCA1 | ATP binding cassette subfamily A member 1 |
19 | O95477 | chr9: 104,781,002-104,928,237 |
ACE | angiotensin I converting enzyme |
1636 | P12821 | chr17: 63,477,061-63,498,380 |
ACVR1 | activin A receptor type I |
90 | Q04771 | chr2: 157,736,444-157,875,862 |
ADIPOQ | adiponectin, C1Q and collagen domain containing |
9370 | Q15848 | chr3: 186,842,690-186,858,463 |
ADIPOR1 | adiponectin receptor 1 |
51094 | Q96A54 | chr1: 202,940,823-202,958,572 |
ADIPOR2 | adiponectin receptor 2 |
79602 | Q86V24 | chr12: 1,688,574-1,788,678 |
ADM | adrenomedullin |
133 | P35318 | chr11: 10,304,680-10,307,397 |
ADRA2B | adrenoceptor alpha 2B |
151 | P18089 | chr2: 96,112,875-96,116,245 |
ADRB2 | adrenoceptor beta 2 |
154 | P07550 | chr5: 148,825,245-148,828,687 |
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
183 | P01019 | chr1: 230,702,523-230,714,297 |
AKR1C3 | aldo-keto reductase family 1, member C3 |
8644 | P42330 | chr10: 5,035,354-5,107,686 |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
207 | P31749 | chr14: 104,769,349-104,795,751 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
208 | P31751 | chr19: 40,230,317-40,285,536 |
AMH | anti-Mullerian hormone |
268 | P03971 | chr19: 2,249,309-2,252,073 |
AMHR2 | anti-Mullerian hormone receptor, type II |
269 | Q16671 | chr12: 53,423,855-53,431,534 |
APLN | apelin |
8862 | Q9ULZ1 | chrX: 129,645,259-129,654,937 |
APOA1 | apolipoprotein A-I |
335 | P02647 | chr11: 116,835,751-116,837,950 |
APOA4 | apolipoprotein A-IV |
337 | P06727 | chr11: 116,820,700-116,823,306 |
APOB | apolipoprotein B |
338 | P04114 | chr2: 21,001,429-21,044,073 |
APOC1 | apolipoprotein C-I |
341 | P02654 | chr19: 44,914,247-44,919,349 |
AQP9 | aquaporin 9 |
366 | O43315 | chr15: 58,138,169-58,185,911 |
BMP15 | bone morphogenetic protein 15 |
9210 | O95972 | chrX: 50,910,784-50,916,607 |
C3 | complement component 3 |
718 | P01024 | chr19: 6,677,704-6,730,562 |
CAPN10 | calpain 10 |
11132 | Q9HC96 | chr2: 240,586,716-240,617,705 |
CAPN5 | calpain 5 |
726 | O15484 | chr11: 77,066,932-77,126,155 |
CCK | cholecystokinin |
885 | P06307 | chr3: 42,257,825-42,266,207 |
CCL2 | chemokine (C-C motif) ligand 2 |
6347 | P13500 | chr17: 34,255,218-34,257,203 |
CD28 | CD28 molecule |
940 | P10747 | chr2: 203,706,475-203,738,912 |
CD36 | CD36 molecule (thrombospondin receptor) |
948 | P16671 | chr7: 80,369,575-80,679,277 |
CD4 | CD4 molecule |
920 | P01730 | chr12: 6,786,858-6,820,808 |
CD40LG | CD40 ligand |
959 | P29965 | chrX: 136,648,193-136,660,390 |
CDKAL1 | CDK5 regulatory subunit associated protein 1-like 1 |
54901 | Q5VV42 | chr6: 20,534,457-21,232,404 |
CHI3L1 | chitinase 3 like 1 |
1116 | P36222 | chr1: 203,178,931-203,186,749 |
CHIT1 | chitinase 1 |
1118 | Q13231 | chr1: 203,212,827-203,273,641 |
COMT | catechol-O-methyltransferase |
1312 | P21964 | chr22: 19,941,607-19,969,975 |
CPB2 | carboxypeptidase B2 |
1361 | Q96IY4 | chr13: 46,053,186-46,105,076 |
CRP | C-reactive protein, pentraxin-related |
1401 | P02741 | chr1: 159,712,289-159,714,589 |
CYP11A1 | cytochrome P450 family 11 subfamily A member 1 |
1583 | P05108 | chr15: 74,337,759-74,367,740 |
CYP11B1 | cytochrome P450 family 11 subfamily B member 1 |
1584 | P15538 | chr8: 142,872,356-142,879,846 |
CYP17A1 | cytochrome P450 family 17 subfamily A member 1 |
1586 | P05093 | chr10: 102,830,531-102,837,533 |
CYP19A1 | cytochrome P450 family 19 subfamily A member 1 |
1588 | P11511 | chr15: 51,208,057-51,338,610 |
CYP1A1 | cytochrome P450 family 1 subfamily A member 1 |
1543 | P04798 | chr15: 74,719,542-74,725,610 |
CYP21A2 | cytochrome P450 family 21 subfamily A member 2 |
1589 | P08686 | chr6: 32,038,265-32,041,670 |
CYP3A7 | CYP3A7-CYP3A51P readthrough |
1551 | P24462 | chr7: 99,705,037-99,735,196 |
CYR61 | cysteine-rich, angiogenic inducer, 61 |
3491 | O00622 | chr1: 85,580,761-85,583,962 |
DENND1A | DENN/MADD domain containing 1A |
57706 | Q8TEH3 | chr9: 123,379,654-123,930,152 |
DRD2 | dopamine receptor D2 |
1813 | P14416 | chr11: 113,409,615-113,475,691 |
EDN1 | endothelin 1 |
1906 | P05305 | chr6: 12,290,363-12,297,194 |
EDN2 | endothelin 2 |
1907 | P20800 | chr1: 41,478,775-41,484,673 |
ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 | P22413 | chr6: 131,808,016-131,895,155 |
ESR1 | estrogen receptor 1 |
2099 | P03372 | chr6: 151,656,691-152,129,619 |
ESR2 | estrogen receptor 2 (ER beta) |
2100 | Q92731 | chr14: 64,084,232-64,338,112 |
F13A1 | coagulation factor XIII, A1 polypeptide |
2162 | P00488 | chr6: 6,144,085-6,321,013 |
F2 | coagulation factor II (thrombin) |
2147 | P00734 | chr11: 46,719,180-46,739,506 |
F5 | coagulation factor V (proaccelerin, labile factor) |
2153 | P12259 | chr1: 169,514,166-169,586,588 |
FABP4 | fatty acid binding protein 4, adipocyte |
2167 | P15090 | chr8: 81,478,419-81,483,263 |
FBN3 | fibrillin 3 |
84467 | Q75N90 | chr19: 8,065,402-8,149,846 |
FEM1A | fem-1 homolog a (C. elegans) |
55527 | Q9BSK4 | chr19: 4,791,681-4,801,273 |
FEM1B | fem-1 homolog b (C. elegans) |
10116 | Q9UK73 | chr15: 68,277,803-68,295,865 |
FOXO1 | forkhead box O1 |
2308 | Q12778 | chr13: 40,469,953-40,666,597 |
FSHR | follicle stimulating hormone receptor |
2492 | P23945 | chr2: 48,962,157-49,154,537 |
FST | follistatin |
10468 | P19883 | chr5: 53,480,409-53,487,134 |
FTO | fat mass and obesity associated |
79068 | Q9C0B1 | chr16: 53,701,692-54,158,512 |
GATA6 | GATA binding protein 6 |
2627 | Q92908 | chr18: 22,169,443-22,202,528 |
GDF9 | growth differentiation factor 9 |
2661 | O60383 | chr5: 132,861,181-132,866,884 |
GH1 | growth hormone 1 |
2688 | P01241 | chr17: 63,917,200-63,918,838 |
GHR | growth hormone receptor |
2690 | P10912 | chr5: 42,423,777-42,721,878 |
GHRL | ghrelin/obestatin prepropeptide |
51738 | Q9UBU3 | chr3: 10,285,675-10,292,947 |
GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
2776 | P50148 | chr9: 77,716,087-78,031,458 |
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 |
2784 | P16520 | chr12: 6,839,954-6,847,393 |
GNRHR | gonadotropin releasing hormone receptor |
2798 | P30968 | chr4: 67,739,328-67,754,360 |
GPER1 | G protein-coupled estrogen receptor 1 |
2852 | Q99527 | chr7: 1,082,208-1,093,815 |
GSK3B | glycogen synthase kinase 3 beta |
2932 | P49841 | chr3: 119,821,323-120,094,417 |
GSTM1 | glutathione S-transferase mu 1 |
2944 | P09488 | chr1: 109,687,814-109,709,039 |
GSTT1 | glutathione S-transferase theta 1 |
2952 | P30711 | chr22: 24,033,952-24,042,493 |
GYS1 | glycogen synthase 1 |
2997 | P13807 | chr19: 48,968,125-48,993,310 |
H6PD | hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
9563 | O95479 | chr1: 9,234,775-9,271,337 |
HAMP | hepcidin antimicrobial peptide |
57817 | P81172 | chr19: 35,280,716-35,285,143 |
HBA1 | hemoglobin subunit alpha 1 |
3039 | P69905 | chr16: 176,680-177,522 |
HDAC3 | histone deacetylase 3 |
8841 | O15379 | chr5: 141,620,876-141,636,870 |
HFE | hemochromatosis |
3077 | Q30201 | chr6: 26,087,281-26,098,343 |
HHEX | hematopoietically expressed homeobox |
3087 | Q03014 | chr10: 92,689,951-92,695,646 |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase |
3156 | P04035 | chr5: 75,336,329-75,362,104 |
HMOX1 | heme oxygenase 1 |
3162 | P09601 | chr22: 35,380,361-35,394,214 |
HOXA10 | homeobox A10 |
3206 | P31260 | chr7: 27,170,591-27,180,261 |
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
3290 | P28845 | chr1: 209,686,178-209,734,950 |
HSD17B1 | hydroxysteroid (17-beta) dehydrogenase 1 |
3292 | P14061 | chr17: 42,549,214-42,555,213 |
HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 |
3028 | Q99714 | chrX: 53,431,258-53,434,373 |
HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 |
3294 | P37059 | chr16: 82,035,004-82,098,534 |
HSD17B6 | hydroxysteroid (17-beta) dehydrogenase 6 |
8630 | O14756 | chr12: 56,752,161-56,787,790 |
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
3283 | P14060 | chr1: 119,507,198-119,515,054 |
IAPP | islet amyloid polypeptide |
3375 | P10997 | chr12: 21,354,959-21,379,978 |
ICAM1 | intercellular adhesion molecule 1 |
3383 | P05362 | chr19: 10,270,835-10,286,615 |
IDE | insulin-degrading enzyme |
3416 | P14735 | chr10: 92,451,684-92,574,076 |
IGF1 | insulin like growth factor 1 |
3479 | P05019 | chr12: 102,395,867-102,480,645 |
IGF2 | insulin like growth factor 2 |
3481 | P01344 | chr11: 2,129,112-2,141,238 |
IGFBP1 | insulin like growth factor binding protein 1 |
3484 | P08833 | chr7: 45,888,357-45,893,668 |
IL10 | interleukin 10 |
3586 | P22301 | chr1: 206,767,602-206,772,494 |
IL18 | interleukin 18 |
3606 | Q14116 | chr11: 112,143,251-112,164,117 |
IL1A | interleukin 1 alpha |
3552 | P01583 | chr2: 112,773,915-112,784,590 |
IL1B | interleukin 1 beta |
3553 | P01584 | chr2: 112,829,751-112,836,903 |
IL1RN | interleukin 1 receptor antagonist |
3557 | P18510 | chr2: 113,107,214-113,134,016 |
IL6 | interleukin 6 |
3569 | P05231 | chr7: 22,725,884-22,732,002 |
IL6ST | interleukin 6 signal transducer |
3572 | P40189 | chr5: 55,935,095-55,994,993 |
INHA | inhibin alpha |
3623 | P05111 | chr2: 219,569,162-219,575,713 |
INHBA | inhibin beta A |
3624 | P08476 | chr7: 41,667,168-41,705,834 |
INHBB | inhibin beta B |
3625 | P09529 | chr2: 120,346,143-120,351,808 |
INHBC | inhibin beta C |
3626 | P55103 | chr12: 57,434,760-57,450,828 |
INS | insulin |
3630 | P01308 | chr11: 2,159,779-2,161,341 |
INSL3 | insulin like 3 |
3640 | P51460 | chr19: 17,816,512-17,821,574 |
INSR | insulin receptor |
3643 | P06213 | chr19: 7,112,255-7,294,034 |
IRS1 | insulin receptor substrate 1 |
3667 | P35568 | chr2: 226,731,317-226,799,759 |
IRS2 | insulin receptor substrate 2 |
8660 | Q9Y4H2 | chr13: 109,752,698-109,786,568 |
IRS4 | insulin receptor substrate 4 |
8471 | O14654 | chrX: 108,732,482-108,736,409 |
ITGAV | integrin subunit alpha V |
3685 | P06756 | chr2: 186,590,065-186,680,901 |
ITGAX | integrin subunit alpha X |
3687 | P20702 | chr16: 31,355,134-31,382,997 |
ITGB3 | integrin subunit beta 3 |
3690 | P05106 | chr17: 47,253,846-47,311,816 |
ITLN1 | intelectin 1 (galactofuranose binding) |
55600 | Q8WWA0 | chr1: 160,876,539-160,885,170 |
KCNJ11 | potassium channel, inwardly rectifying subfamily J, member 11 |
3767 | Q14654 | chr11: 17,385,859-17,389,331 |
KISS1 | KiSS-1 metastasis-suppressor |
3814 | Q15726 | chr1: 204,190,341-204,196,486 |
KLK3 | kallikrein related peptidase 3 |
354 | P07288 | chr19: 50,854,915-50,860,764 |
KRAS | Kirsten rat sarcoma viral oncogene homolog |
3845 | P01116 | chr12: 25,204,789-25,250,936 |
LCN2 | lipocalin 2 |
3934 | P80188 | chr9: 128,149,071-128,153,455 |
LEP | leptin |
3952 | P41159 | chr7: 128,241,284-128,257,628 |
LEPR | leptin receptor |
3953 | P48357 | chr1: 65,420,652-65,641,559 |
LHB | luteinizing hormone beta polypeptide |
3972 | P01229 | chr19: 49,015,980-49,017,081 |
LHCGR | luteinizing hormone/choriogonadotropin receptor |
3973 | P22888 | chr2: 48,686,775-48,755,730 |
LIPE | lipase, hormone-sensitive |
3991 | Q05469 | chr19: 42,401,507-42,427,426 |
LMNA | lamin A/C |
4000 | P02545 | chr1: 156,082,573-156,140,089 |
LPIN1 | lipin 1 |
23175 | Q14693 | chr2: 11,677,595-11,827,409 |
LPP | LIM domain containing preferred translocation partner in lipoma |
4026 | Q93052 | chr3: 188,153,284-188,890,671 |
MC4R | melanocortin 4 receptor |
4160 | P32245 | chr18: 60,371,110-60,372,775 |
MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 |
23101 | Q86YR7 | chr3: 183,178,043-183,428,778 |
MGAM | maltase-glucoamylase |
8972 | O43451 | chr7: 141,907,813-142,106,747 |
MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
4282 | P14174 | chr22: 23,894,004-23,895,227 |
MMP2 | matrix metallopeptidase 2 |
4313 | P08253 | chr16: 55,389,700-55,506,691 |
MMP26 | matrix metallopeptidase 26 |
56547 | Q9NRE1 | chr11: 4,704,927-4,992,429 |
MMP8 | matrix metallopeptidase 8 |
4317 | P22894 | chr11: 102,711,795-102,727,050 |
MMP9 | matrix metallopeptidase 9 |
4318 | P14780 | chr20: 46,008,908-46,016,561 |
MSTN | myostatin |
2660 | O14793 | chr2: 190,055,697-190,062,729 |
MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
4524 | P42898 | chr1: 11,785,723-11,806,920 |
MTNR1A | melatonin receptor 1A |
4543 | P48039 | chr4: 186,533,655-186,555,567 |
MTNR1B | melatonin receptor 1B |
4544 | P49286 | chr11: 92,969,720-92,985,066 |
NAMPT | nicotinamide phosphoribosyltransferase |
10135 | P43490 | chr7: 106,248,285-106,286,326 |
NCOR1 | nuclear receptor corepressor 1 |
9611 | O75376 | chr17: 16,029,157-16,218,185 |
NFIC | nuclear factor I/C (CCAAT-binding transcription factor) |
4782 | P08651 | chr19: 3,314,403-3,469,217 |
NOS3 | nitric oxide synthase 3 |
4846 | P29474 | chr7: 150,990,995-151,014,588 |
NPPB | natriuretic peptide B |
4879 | P16860 | chr1: 11,857,464-11,858,931 |
NR1H3 | nuclear receptor subfamily 1 group H member 3 |
10062 | Q13133 | chr11: 47,248,300-47,269,032 |
NR3C1 | nuclear receptor subfamily 3 group C member 1 |
2908 | P04150 | chr5: 143,277,931-143,435,512 |
NRIP1 | nuclear receptor interacting protein 1 |
8204 | P48552 | chr21: 14,961,235-15,065,936 |
NUCB2 | nucleobindin 2 |
4925 | P80303 | chr11: 17,208,153-17,349,974 |
PAEP | progestagen-associated endometrial protein |
5047 | P09466 | chr9: 135,561,756-135,566,955 |
PDE8A | phosphodiesterase 8A |
5151 | O60658 | chr15: 84,980,440-85,139,145 |
PECAM1 | platelet/endothelial cell adhesion molecule 1 |
5175 | P16284 | chr17: 64,319,415-64,413,776 |
PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
5295 | P27986 | chr5: 68,215,720-68,301,821 |
PLA2G7 | phospholipase A2 group VII |
7941 | Q13093 | chr6: 46,704,201-46,735,693 |
PLAT | plasminogen activator, tissue |
5327 | P00750 | chr8: 42,175,233-42,207,724 |
PLAUR | plasminogen activator, urokinase receptor |
5329 | Q03405 | chr19: 43,646,095-43,670,547 |
PLIN1 | perilipin 1 |
5346 | O60240 | chr15: 89,664,365-89,679,427 |
PNPLA2 | patatin like phospholipase domain containing 2 |
57104 | Q96AD5 | chr11: 818,902-825,573 |
POMC | proopiomelanocortin |
5443 | P01189 | chr2: 25,160,853-25,168,903 |
PON1 | paraoxonase 1 |
5444 | P27169 | chr7: 95,297,676-95,324,707 |
PPARG | peroxisome proliferator-activated receptor gamma |
5468 | P37231 | chr3: 12,287,368-12,434,356 |
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
10891 | Q9UBK2 | chr4: 23,755,041-23,904,089 |
PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
5563 | P54646 | chr1: 56,645,322-56,715,335 |
PRKAG3 | protein kinase, AMP-activated, gamma 3 non-catalytic subunit |
53632 | Q9UGI9 | chr2: 218,822,383-218,832,086 |
PRKAR2B | protein kinase, cAMP-dependent, regulatory subunit type II beta |
5577 | P31323 | chr7: 107,044,649-107,161,811 |
PTEN | phosphatase and tensin homolog |
5728 | P60484 | chr10: 87,863,113-87,971,930 |
PTH | parathyroid hormone |
5741 | P01270 | chr11: 13,492,055-13,496,181 |
PTX3 | pentraxin 3 |
5806 | P26022 | chr3: 157,436,789-157,443,628 |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 |
5921 | P20936 | chr5: 87,267,888-87,391,931 |
RBP4 | retinol binding protein 4 |
5950 | P02753 | chr10: 93,591,687-93,601,744 |
RETN | resistin |
56729 | Q9HD89 | chr19: 7,669,044-7,670,454 |
SAA1 | serum amyloid A1 |
6288 | P0DJI8 | chr11: 18,266,174-18,269,977 |
SERPINA12 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
145264 | Q8IW75 | chr14: 94,487,274-94,517,844 |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 | P05121 | chr7: 101,127,089-101,139,266 |
SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
5176 | P36955 | chr17: 1,761,959-1,777,574 |
SGTA | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
6449 | O43765 | chr19: 2,754,714-2,783,371 |
SHBG | sex hormone-binding globulin |
6462 | P04278 | chr17: 7,613,946-7,633,383 |
SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 |
6580 | O15245 | chr6: 160,121,789-160,158,718 |
SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
6517 | P14672 | chr17: 7,281,667-7,288,257 |
SLC30A8 | solute carrier family 30 (zinc transporter), member 8 |
169026 | Q8IWU4 | chr8: 116,950,273-117,176,714 |
SLC5A3 | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
6526 | P53794 | chr21: 34,073,570-34,106,262 |
SORBS1 | sorbin and SH3 domain containing 1 |
10580 | Q9BX66 | chr10: 95,311,771-95,561,414 |
SOS1 | SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 | Q07889 | chr2: 38,981,396-39,124,345 |
SPP1 | secreted phosphoprotein 1 |
6696 | P10451 | chr4: 87,975,650-87,983,426 |
SRD5A1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
6715 | P18405 | chr5: 6,633,343-6,674,386 |
SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
6716 | P31213 | chr2: 31,522,480-31,581,067 |
SREBF1 | sterol regulatory element binding transcription factor 1 |
6720 | P36956 | chr17: 17,810,399-17,837,002 |
SULT2A1 | sulfotransferase family 2A member 1 |
6822 | Q06520 | chr19: 47,870,466-47,886,397 |
TBC1D4 | TBC1 domain family member 4 |
9882 | O60343 | chr13: 75,284,665-75,482,114 |
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) |
6934 | Q9NQB0 | chr10: 112,950,250-113,167,678 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TGFB2 | transforming growth factor beta 2 |
7042 | P61812 | chr1: 218,346,235-218,444,619 |
TGFBR3 | transforming growth factor beta receptor III |
7049 | Q03167 | chr1: 91,680,343-91,906,335 |
THADA | thyroid adenoma associated |
63892 | Q6YHU6 | chr2: 43,230,836-43,596,046 |
TIMP1 | TIMP metallopeptidase inhibitor 1 |
7076 | P01033 | chrX: 47,582,313-47,586,789 |
TIMP2 | TIMP metallopeptidase inhibitor 2 |
7077 | P16035 | chr17: 78,852,977-78,925,387 |
TM4SF4 | transmembrane 4 L six family member 4 |
7104 | P48230 | chr3: 149,473,974-149,503,281 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TNFRSF11A | tumor necrosis factor receptor superfamily member 11a |
8792 | Q9Y6Q6 | chr18: 62,325,287-62,391,292 |
TNFRSF11B | tumor necrosis factor receptor superfamily member 11b |
4982 | O00300 | chr8: 118,923,557-118,952,200 |
TNFRSF1B | tumor necrosis factor receptor superfamily member 1B |
7133 | P20333 | chr1: 12,167,003-12,209,228 |
TOR2A | torsin family 2, member A |
27433 | Q5JU69 | chr9: 127,731,524-127,735,317 |
TOR2A | torsin family 2, member A |
27433 | Q8N2E6 | chr9: 127,731,524-127,735,317 |
TRIB3 | tribbles pseudokinase 3 |
57761 | Q96RU7 | chr20: 362,835-397,559 |
UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) |
7351 | P55851 | chr11: 73,974,667-73,983,307 |
VCAM1 | vascular cell adhesion molecule 1 |
7412 | P19320 | chr1: 100,719,742-100,739,045 |
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor |
7421 | P11473 | chr12: 47,841,537-47,943,048 |
VEGFA | vascular endothelial growth factor A |
7422 | P15692 | chr6: 43,770,184-43,786,487 |
WT1 | Wilms tumor 1 |
7490 | P19544 | chr11: 32,387,775-32,435,630 |
XDH | xanthine dehydrogenase |
7498 | P47989 | chr2: 31,334,321-31,414,715 |
YAP1 | Yes associated protein 1 |
10413 | P46937 | chr11: 102,110,461-102,233,423 |